ESG Performance Report 2022 (PDF - 1.2MB) Annual Report 2022 iXBRL viewer Annual Report 2022 ESEF (ZIP - 13.5MB) 20-F 2022 (PDF - 4.1MB) Download all Corporate reporting 2022 02 March 2022 Corporate reporting 2021 Annual Report 2021 (PDF - 4.8MB) ESG Performance Summary 2021 ...
Issued: 8 March 2022, London UK GlaxoSmithKline plcAnnual Report 2021 on Form 20-F In accordance with Section 203.
GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 GSK plc at a glance Our purpose We unite science, technology and talent to get ahead of disease together For health impact + shareholder returns + thriving people About our new logo The new logo reflects our new purpose and growth ...
Annual report 2021 [https://www.gsk.com/media/7462/annual-report-2021.pdf]. 9 GSK globally The company offers a portfolio of vaccines, specialty medicines and general medicines across 4 major therapeutic areas: infectious diseases, HIV, oncology and respiratory/ immunology. 1.2 Product portfolio ...
Such factors include, but are not limited to, those discussed under Item 3.D ‘Risk Factors’ in GSK’s Annual Report on Form 20-F for 2021, GSK’s Q1 Results for 2022 and any impacts of the COVID-19 pandemic. Any forward-looking statements made by or on behalf of GSK speak only ...
This statistic was assembled from several editions of the GSK Annual Report. * Reflects the spin-off of the Consumer Healthcare business. Open this statistic in... Spanish Citation formats Citation formats View options Other statistics on the topicPharmaceutical industry in the UK ...
GlaxoSmithKline (n.d.). Annual Report 2017. Retrieved fromhttps://www.gsk.com/media/4751/annual-report.pdf GlaxoSmithKline. (2014, March 27). GlaxoSmithKline recalls alli® . Retrieved fromhttps://www.prnewswire.com/news-releases/glaxosmithkline-recalls-alli-252632091.html ...
GSK GB00BN7SWP63 Pharmaceuticals Market Closed -London S.E. 11:35:06 2025-01-14 am EST5-day change1st Jan Change 1,293.50GBX-2.82% -4.15%-3.94% 06:26pmPfizer to more than halve Haleon holding in GBP2.57 billion saleAN 04:30pmGSK plc Presents at 43rd Annual J.P. Morgan Healthca...
including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described under Item 3.D “Risk factors...
Such factors include, but are not limited to, those described under Item 3.D 'Risk factors” in the company's Annual Report on Form 20-F for 2022, and Q2 Results for 2023 and any impacts of the COVID-19 pandemic.References[1] Naymagon, ...